Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Francesca Imbastari

Francesca Imbastari

Institutions of which they are part

Administration and Management
Liver Diseases
Vall Hebron Institut de Recerca
Francesca Imbastari

Francesca Imbastari

Francesca Imbastari

Institutions of which they are part

Administration and Management
Liver Diseases
Vall Hebron Institut de Recerca

Related news

Dr. Raul Herance

We develop a method to diagnose fatty liver in a quantitative and non-invasive way

Using computed tomography (CT), with or without contrast, it is possible to perform an accurate and safe detection of the disease without the need for biopsies and avoiding the limitations of other non-invasive diagnostic tools.

Grup de Malalties Hepàtiques del VHIR

A clinical trial has led to approval of the first drug for advanced fatty liver disease

Preliminary study results confirm that the drug resmetirom reduces the presence of fat, inflammation, cell damage and fibrosis in the liver.

Equip projecte ARTEMIs

We study fatty liver and cardiovascular complications with digital twins

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

See more

Related professionals

Almudena Felipe Montiel

Almudena Felipe Montiel

Predoctoral researcher
Pneumology
Read more
Christina Regales Peco

Christina Regales Peco

Predoctoral researcher
Psychiatry, Mental Health and Addictions
Read more
Sergio Huertas Torres

Sergio Huertas Torres

Research technician
Transfusional Medicine
Read more
Soraya Micó Milla

Soraya Micó Milla

Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.